Identification of inflammatory factor-related genes associated with the prognosis and immune cell infiltration in colorectal cancer patients

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590 Tuomisto, 2019, Systemic inflammation in colorectal cancer: underlying factors, effects, and prognostic significance, World J Gastroenterol, 25, 4383, 10.3748/wjg.v25.i31.4383 Chen, 2017, Systemic immune-inflammation index for predicting prognosis of colorectal cancer, World J Gastroenterol, 23, 6261, 10.3748/wjg.v23.i34.6261 McMillan, 2013, The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer, Cancer Treat Rev, 39, 534, 10.1016/j.ctrv.2012.08.003 Terzić, 2010, Inflammation and colon cancer, Gastroenterology, 138, 2101, 10.1053/j.gastro.2010.01.058 Ullman, 2011, Intestinal inflammation and cancer, Gastroenterology, 140, 1807, 10.1053/j.gastro.2011.01.057 Li, 2012, IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer, Carcinogenesis, 33, 1889, 10.1093/carcin/bgs214 O'Connor, 2010, Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease, Inflamm Bowel Dis, 16, 1411, 10.1002/ibd.21217 Luo, 2019, LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer, J Exp Clin Cancer Res, 38, 249, 10.1186/s13046-019-1263-3 Bullock, 2013, FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role, Br J Cancer, 109, 387, 10.1038/bjc.2013.355 Dmitrieva-Posocco, 2019, Cell-type-specific responses to interleukin-1 control microbial invasion and tumor-elicited inflammation in colorectal cancer, Immunity, 50, 166, 10.1016/j.immuni.2018.11.015 Sung, 2021, Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J Clin, 71, 209, 10.3322/caac.21660 Schwabe, 2013, The microbiome and cancer, Nat Rev Cancer, 13, 800, 10.1038/nrc3610 Del Cornò, 2019, Transcriptome profiles of human visceral adipocytes in obesity and colorectal cancer unravel the effects of body mass index and polyunsaturated fatty acids on genes and biological processes related to tumorigenesis, Front Immunol, 10, 265, 10.3389/fimmu.2019.00265 Jess, 2012, Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies, Clin Gastroenterol Hepatol, 10, 639, 10.1016/j.cgh.2012.01.010 Becker, 2005, IL-6 signaling promotes tumor growth in colorectal cancer, Cell Cycle, 4, 217, 10.4161/cc.4.2.1413 Popivanova, 2008, Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis, J Clin Invest, 118, 560 De Simone, 2015, Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth, Oncogene, 34, 3493, 10.1038/onc.2014.286 Lindemans, 2015, Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration, Nature, 528, 560, 10.1038/nature16460 Huber, 2012, IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine, Nature, 491, 259, 10.1038/nature11535 Li, 2021, Screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers, Biosci Rep, 41, 10.1042/BSR20203496 Reubi, 2000, Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin, Cancer Res, 60, 3105 Vinuesa, 2012, Vanilloid receptor-1 regulates neurogenic inflammation in colon and protects mice from colon cancer, Cancer Res, 72, 1705, 10.1158/0008-5472.CAN-11-3693 Xiao, 2019, miR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma, Aging, 11, 615, 10.18632/aging.101763 Gao, 2020, Identification of genes related to clinicopathological characteristics and prognosis of patients with colorectal cancer, DNA Cell Biol, 39, 690, 10.1089/dna.2019.5088 Maddalena, 2011, Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis, Cancer Res, 71, 7659, 10.1158/0008-5472.CAN-11-2172 Cheadle, 2007, Eotaxin-2 and colorectal cancer: a potential target for immune therapy, Clin Cancer Res, 13, 5719, 10.1158/1078-0432.CCR-07-1145 Olsen, 2017, Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer, World J Gastroenterol, 23, 6212, 10.3748/wjg.v23.i34.6212 Liu, 2020, Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis, Biosci Rep, 40, 10.1042/BSR20200141 Chida, 2016, Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer, Carcinogenesis, 37, 878, 10.1093/carcin/bgw069 Cui, 2019, MMP14 predicts a poor prognosis in patients with colorectal cancer, Hum Pathol, 83, 36, 10.1016/j.humpath.2018.03.030 Hu, 2020, HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer, J Exp Clin Cancer Res, 39, 270, 10.1186/s13046-020-01783-9 Yu, 2016, TNFAIP6 is a potential biomarker of disease activity in inflammatory bowel disease, Biomarkers Med, 10, 473, 10.2217/bmm.16.9 Offenberg, 2008, TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles, Mol Oncol, 2, 233, 10.1016/j.molonc.2008.06.003 Liu, 2021, Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods, Sci Rep, 11, 15040, 10.1038/s41598-021-94541-6 Miyoshi, 2009, RGS16 is a marker for prognosis in colorectal cancer, Ann Surg Oncol, 16, 3507, 10.1245/s10434-009-0690-3 Huang, 2019, TIMP1 is a potential key gene associated with the pathogenesis and prognosis of ulcerative colitis-associated colorectal cancer, OncoTargets Ther, 12, 8895, 10.2147/OTT.S222608 Zhao, 2020, Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer, J Hematol Oncol, 13, 156, 10.1186/s13045-020-00991-2 Liu, 2020, Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway, Cell Death Differ, 27, 1765, 10.1038/s41418-019-0460-0 Corrales, 2015, Molecular pathways: targeting the Stimulator of Interferon Genes (STING) in the immunotherapy of cancer, Clin Cancer Res, 21, 4774, 10.1158/1078-0432.CCR-15-1362 Chon, 2019, STING signaling is a potential immunotherapeutic target in colorectal cancer, J Cancer, 10, 4932, 10.7150/jca.32806 Deng, 2019, Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer, Theranostics, 9, 1001, 10.7150/thno.30056 Pérez, 2020, N-glycosylation and receptor tyrosine kinase signaling affect claudin-3 levels in colorectal cancer cells, Oncol Rep, 44, 1649 Jeong, 2018, Inhibiting focal adhesion kinase: a potential target for enhancing therapeutic efficacy in colorectal cancer therapy, World J Gastrointest Oncol, 10, 290, 10.4251/wjgo.v10.i10.290 Machackova, 2020, miR-215-5p reduces liver metastasis in an experimental model of colorectal cancer through regulation of ECM-receptor interactions and focal adhesion, Cancers, 12, 3518, 10.3390/cancers12123518